Thursday, June 4, 2020

U.S. doctors group sues FDA for limiting access to drug touted by Trump for COVID-19

U.S. doctors group sues FDA for limiting access to drug touted by Trump for COVID-19The lawsuit represents the latest front in a highly politicized U.S. debate over access to hydroxychloroquine. The drug has been championed by President Donald Trump as a potential "game-changer" against the coronavirus, but its value has yet to be established. A clinical trial released on Wednesday found it to be ineffective in preventing infection.




from Yahoo News - Latest News & Headlines https://ift.tt/2U9hE7x

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Telephone therapy reduces fatigue interference with activities, mood and cognition for metastatic breast cancer survivors

A clinical trial demonstrates the effectiveness of telephone-delivered acceptance and commitment therapy (ACT) in reducing fatigue's int...